Carbidopa?(Lodosyn) is a?drug?given to people with?Parkinson\'s disease?in order to inhibit?peripheral?metabolism?oflevodopa. This property is significant in that it allows a greater proportion of peripheral?levodopa?to cross the blood?brain barrier for central nervous system effect. More information please visit the website: http://www.creative-peptides.com/product/carbidopa-item-10-101-135-25.html